We are seeing patients in-person and through Video Visits. Learn more about how we’re keeping you safe and please review our updated visitor policy. Please also consider supporting Weill Cornell Medicine’s efforts to support our front-line workers.
Sandra and Edward Meyer Cancer Center

Warning message

The subscription service is currently unavailable. Please try again later.

You are here


The Value of MIPI and Ki-67 in Mantle Cell Lymphoma

Thursday, December 28, 2017

 John P. Leonard, M.D., interim chair of the Department of Medicine, associate dean of clinical research, Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, professor of medicine, hosts a panel discussion on the topic of Mantle Cell Lymphoma International Prognostic Index. The Index evaluates four components (age, leukocytosis, lactate dehydrogenase, and performance status) under three categories: high risk, intermediate risk, and low risk.